Cancer of Colon Clinical Trial
Official title:
Colorectal Health Research Champions
Verified date | February 2024 |
Source | Virginia Commonwealth University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the Colorectal Health Research Champions program is to provide accurate and reliable colorectal health cancer information that they can share within their communities to encourage cancer prevention, screening, and early detection, as well as the importance of participating in research.
Status | Terminated |
Enrollment | 91 |
Est. completion date | May 15, 2023 |
Est. primary completion date | May 15, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 30 Years to 99 Years |
Eligibility | Inclusion Criteria: the individual is > 30 years of age - They are literate - They are/were directly or indirectly impacted by colorectal cancer and interested in becoming a champion for colorectal cancer research. To participate in a chat hosted by the CHRC the inclusion criteria is: - adult of any gender - over 30 years of age. Exclusion Criteria for chat hosted by the CHRC: -Those < 30 years of age |
Country | Name | City | State |
---|---|---|---|
United States | Virginia Commonwealth University | Richmond | Virginia |
Lead Sponsor | Collaborator |
---|---|
Virginia Commonwealth University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Increase in participants knowledge and intentions related to colorectal cancer screening. | Participant knowledge will be measured using pre/post questionnaires, with each correct answer being worth one point (14 total points) Higher summary scores indicate a greater change in knowledge. Intentions are measured on a 5 -point likert scale. | 4 months | |
Primary | Increase in knowledge and intentions related to biospecimen donation and clinical trial participation. | Participant knowledge and intentions related to biospecimen donation and clinical trial participation will be measured using pre/post questionnaires, with each correct answer being worth one point (20 total points). Higher summary scores indicate a greater change in knowledge. Intentions are measured on a 5 -point likert scale. | 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06454071 -
Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients
|
Phase 2 | |
Recruiting |
NCT05982184 -
Effect of Music Prehabilitation on Preoperative Anxiety Before Surgery
|
N/A | |
Completed |
NCT04160650 -
Educational Nursing Intervention Among Patients With Colorectal Cancer During Chemotherapy
|
N/A | |
Recruiting |
NCT05179824 -
Tempus Priority Study: A Pan-tumor Observational Study
|
||
Completed |
NCT04716010 -
Developing and Evaluating Product Messaging
|
N/A | |
Terminated |
NCT03524820 -
Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer
|
Phase 2 | |
Active, not recruiting |
NCT02458664 -
BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer
|
N/A | |
Completed |
NCT03246438 -
Choice Architecture and Colorectal Cancer Screening Outreach
|
N/A | |
Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
Not yet recruiting |
NCT03910283 -
Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer
|
N/A | |
Completed |
NCT03928678 -
Implementation of Enhanced Recovery After Surgery Program (ERAS) in Colorectal Cancer Surgery, a Randomized Controlled Trial
|
N/A | |
Completed |
NCT03546569 -
Tumor Cells, Tumor DNA and Immunological Response in Colonic Stent Placement
|
||
Recruiting |
NCT03896958 -
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
|
||
Not yet recruiting |
NCT06035731 -
Evaluation of the Medical Service by Socio-aesthetics in Oncology
|
N/A | |
Completed |
NCT04971304 -
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
|
||
Completed |
NCT05030090 -
Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer
|
N/A | |
Not yet recruiting |
NCT04773626 -
Tumor Deposits in Cancer Colon
|
||
Recruiting |
NCT05887531 -
Abdominopelvic Cancer Prehabilitation
|
N/A | |
Withdrawn |
NCT04274790 -
Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer
|
||
Completed |
NCT03416777 -
Meat-based Versus Pesco-vegetarian Diet and Colorectal Cancer
|
N/A |